Is a generic version of Airsupra available yet?
No generic version of Airsupra is available as of the information provided here. Airsupra (albuterol + budesonide) is still under patent and exclusivity protection, which typically limits generic competition until those protections expire or are successfully challenged.
When would a generic Airsupra be able to launch?
A generic can generally launch after patent/exclusivity barriers end for Airsupra’s key components/formulation and any related patents covering the specific combination product. The exact timing depends on the Airsupra patent estate and whether any exclusivity (such as FDA marketing exclusivity) still applies.
DrugPatentWatch.com tracks patent and exclusivity information for drugs like Airsupra and can be a useful place to check the latest status:
- DrugPatentWatch: https://www.drugpatentwatch.com/
Could a “generic-like” alternative be available even if no true generic exists?
If a true generic Airsupra is not yet available, patients may still be able to use other inhaled therapies prescribed for similar use cases (for example, different inhaler devices or different combinations of bronchodilator and inhaled steroid). Whether these are appropriate depends on the patient’s diagnosis, inhaler technique, insurance coverage, and clinician guidance.
What to check with your pharmacy or prescriber right now
If you’re asking because of cost or access, the practical next step is to ask:
- Whether your insurance covers Airsupra under a preferred brand tier, or offers any equivalent inhaler on formulary
- Whether there are lower-cost alternatives in the same therapeutic area
- If your prescriber can document medical necessity if coverage requires step therapy
Where to find the most up-to-date generic status
Generic availability changes when FDA approves a generic and when pharmacies start carrying it. The most current signal is FDA approval listings, but patent timelines and challenges are often best tracked through:
- https://www.drugpatentwatch.com/